Sabby Management’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
Other funds holding TPST
Sabby Management's TPST Position: Q3 2026 in Review
Sabby Management sold out of Tempest Therapeutics (TPST) in Q3 2026, closing a stake of 511,286 shares — an estimated $568K sold.
Sabby Management first reported a position in TPST in Q3 2013 and held it in 21 quarters. The position peaked at $10.3M in Q2 2015. 24 funds tracked by Wall St. Rank hold TPST as of Q3 2026.
- Sabby Management reported no remaining Tempest Therapeutics position as of Q3 2026 after selling out during the quarter.
- Sabby Management sold 511,286 Tempest Therapeutics shares in Q3 2026, an estimated $568K.
- Sabby Management first reported a position in Tempest Therapeutics in Q3 2013 and held it in 21 quarters.
- Sabby Management's Tempest Therapeutics position peaked at $10.3M in Q2 2015.
- 24 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2026.
Based on Sabby Management's 13F filing for Q3 2026, filed 13 Nov 2026.